GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Xtant Medical Holdings Inc (STU:XMS) » Definitions » Net Margin %

Xtant Medical Holdings (STU:XMS) Net Margin % : -15.79% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Xtant Medical Holdings Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Xtant Medical Holdings's Net Income for the three months ended in Mar. 2024 was €-4.05 Mil. Xtant Medical Holdings's Revenue for the three months ended in Mar. 2024 was €25.64 Mil. Therefore, Xtant Medical Holdings's net margin for the quarter that ended in Mar. 2024 was -15.79%.

The historical rank and industry rank for Xtant Medical Holdings's Net Margin % or its related term are showing as below:

STU:XMS' s Net Margin % Range Over the Past 10 Years
Min: -97.09   Med: -13.91   Max: 0.72
Current: -1.64


STU:XMS's Net Margin % is ranked worse than
50.24% of 822 companies
in the Medical Devices & Instruments industry
Industry Median: -1.34 vs STU:XMS: -1.64

Xtant Medical Holdings Net Margin % Historical Data

The historical data trend for Xtant Medical Holdings's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xtant Medical Holdings Net Margin % Chart

Xtant Medical Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.71 -13.17 -8.77 -14.64 0.72

Xtant Medical Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -11.58 -10.82 36.89 -15.31 -15.79

Competitive Comparison of Xtant Medical Holdings's Net Margin %

For the Medical Devices subindustry, Xtant Medical Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xtant Medical Holdings's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Net Margin % distribution charts can be found below:

* The bar in red indicates where Xtant Medical Holdings's Net Margin % falls into.



Xtant Medical Holdings Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Xtant Medical Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=0.605/83.725
=0.72 %

Xtant Medical Holdings's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-4.048/25.643
=-15.79 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Xtant Medical Holdings  (STU:XMS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Xtant Medical Holdings Net Margin % Related Terms

Thank you for viewing the detailed overview of Xtant Medical Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Xtant Medical Holdings (STU:XMS) Business Description

Traded in Other Exchanges
Address
664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.

Xtant Medical Holdings (STU:XMS) Headlines

No Headlines